Special Offer Tirzepatide
US$ 26.49
pros and cons of glp-1 medications Weight Loss: Drugs Long-term Success of GLP-1s Hinges
Description
doi: 10.1016/j.colsurfb.2024.114087 [DOI] [PubMed] [Google Scholar] 42.Yin Y, Li X, Wang M, Ling G, Zhang P
3 GLUCERNA IS THE ONLY DSNF BACKED BY OVER 30 YEARS OF RESEARCH ^ Glucerna is formulated specifically for people with diabetes or impaired glucose tolerance, with a low GI slow-release carbohydrate blend aiding slower glucose absorption
Oral semaglutide starts at $249 per month
Pharma may invest in advocacy for anti-hunger/disease arguments
Cost is the primary factor driving payers to restrict GLP-1 coverage
